Cytokinetics, Inc. (CYTK)
65.60
-0.02
(-0.03%)
USD |
NASDAQ |
Oct 02, 16:00
65.59
-0.01
(-0.02%)
After-Hours: 20:00
Cytokinetics Net Income (Quarterly) : -198.76M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -198.76M |
| March 31, 2026 | -206.03M |
| December 31, 2025 | -183.03M |
| September 30, 2025 | -306.18M |
| June 30, 2025 | -134.37M |
| March 31, 2025 | -161.38M |
| December 31, 2024 | -150.02M |
| September 30, 2024 | -160.54M |
| June 30, 2024 | -143.32M |
| March 31, 2024 | -135.64M |
| December 31, 2023 | -136.90M |
| September 30, 2023 | -129.42M |
| June 30, 2023 | -128.64M |
| March 31, 2023 | -131.29M |
| December 31, 2022 | -137.38M |
| September 30, 2022 | -142.31M |
| June 30, 2022 | -19.82M |
| March 31, 2022 | -89.44M |
| December 31, 2021 | -30.57M |
| September 30, 2021 | -76.09M |
| June 30, 2021 | -61.55M |
| March 31, 2021 | -47.10M |
| December 31, 2020 | -43.93M |
| September 30, 2020 | -3.175M |
| June 30, 2020 | -40.78M |
| Date | Value |
|---|---|
| March 31, 2020 | -39.40M |
| December 31, 2019 | -30.64M |
| September 30, 2019 | -29.57M |
| June 30, 2019 | -32.11M |
| March 31, 2019 | -29.37M |
| December 31, 2018 | -26.47M |
| September 30, 2018 | -22.02M |
| June 30, 2018 | -27.52M |
| March 31, 2018 | -30.28M |
| December 31, 2017 | -40.48M |
| September 30, 2017 | -32.36M |
| June 30, 2017 | -29.08M |
| March 31, 2017 | -25.87M |
| December 31, 2016 | 7.157M |
| September 30, 2016 | 33.36M |
| June 30, 2016 | -11.61M |
| March 31, 2016 | -12.46M |
| December 31, 2015 | -9.229M |
| September 30, 2015 | -8.849M |
| June 30, 2015 | -10.55M |
| March 31, 2015 | -8.872M |
| December 31, 2014 | 8.443M |
| September 30, 2014 | -5.971M |
| June 30, 2014 | -8.374M |
| March 31, 2014 | -8.744M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 3.316B |
| Ionis Pharmaceuticals, Inc. | -114.65M |
| Vertex Pharmaceuticals, Inc. | 1.100B |
| Krystal Biotech, Inc. | 54.77M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 28.62M |
| Total Expenses (Quarterly) | 227.39M |
| EPS Diluted (Quarterly) | -1.505 |
| Enterprise Value | 9.205B |
| Gross Profit Margin (Quarterly) | 67.78% |
| Profit Margin (Quarterly) | -694.4% |
| Earnings Yield | -11.01% |
| Normalized Earnings Yield | -10.05 |